Genomics in Cancer Care Market
Genomics in Cancer Care Market - Global Industry Assessment & Forecast
#
Pages:
167
2022
Feb - 2022
VMR-1285
Segments Covered
By
Product Instruments, Consumables, Services
-
By
Application Diagnostics, Personalized Medicine, Drug Discovery & Development, Research
-
By
Technology Genome Sequencing, PCR, Microarrays, Nucleic Acid Extraction & Purification, Other
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 13.91 Billion |
 Revenue 2030:
|
USD 45.27 Billion |
 Revenue CAGR
(2023 - 2030): |
15.90% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Research Methodology: Genomics in Cancer Care Market by Product by Application by Technology by Region - Global Market Assessment, 2021 - 2028
Secondary Research
Primary Research:
Data Triangulation and Market Size Estimations
Vantage Market
Research | 24-Feb-2022
FAQ
Frequently Asked Question
What is the global demand for Genomics in Cancer Care in terms of revenue?
-
The global Genomics in Cancer Care valued at USD 13.91 Billion in 2022 and is expected to reach USD 45.27 Billion in 2030 growing at a CAGR of 15.90%.
Which are the prominent players in the market?
-
The prominent players in the market are Agilent Technologies, Illumina, Inc., Pacific Biosciences, Inc., ThermoFisher Scientific Inc., Intrexon Bioinformatics Germany GmbH are the major companies operating in Global Genomics in Cancer Care Market..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 15.90% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Genomics in Cancer Care include
- Supportive Government Policies
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Genomics in Cancer Care in 2022.
